Analysts estimate that QuantumScape will report an earnings per share (EPS) of $-0.19. QuantumScape bulls will hope to hear the company announce they've not only beaten that estimate, but also to ...

Valued at a market cap of $117.7 billion, Vertex Pharmaceuticals Incorporated (VRTX) is a biotechnology company that ...

Explore why QuantumScape Corporation's recent drop may present a buying opportunity ahead of Q2 earnings. Click for my ...

QuantumScape shares are trading higher Tuesday afternoon. The stock is rebounding ahead of its Q2 earnings report, scheduled ...

Despite its promise, QuantumScape faces substantial risks. The company is pre-revenue, with no commercial contracts, raising doubts about its ability to deliver. Its cash burn is significant, with ...

QuantumScape (QS) stock is coming off of a remarkable rally, reaching a new 52-week high of $15.03 on July 18 to cap off a nine-day win streak leading up to its Q2 earnings release on July 23. The ...